StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report published on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance NYSE BTX opened at $1.89 on Friday. The company has a market cap of $111.18 million, a P/E ratio of -0.83 and a beta […]